Exclusive from BIO-Europe 2015: Interview with F-star, a Cambridge-UK Immuno-oncology Biotech

03/11/2015 - 1 minute

Second interview of BIO-Europe 2015. This time, it’s a British company from Cambridge (UK): F-star. This morning we spoke with their CBO Jane Dancer.

pic-global-header-logo-fstarF-star is developing bi-specific antibodies for immuno-oncology and inflammatory disease. It has raised a total of 38 million euros from top EU VCs. Jane Dancer’s business tenure within the field is impressive, with 5 years at MedImmune and 4 years experience with Cellzome, supported by a PhD and MBA in the life sciences field from the University of Cambridge.

It was great being able to talk with Jane about F-star’s bi-specific antibody platform, the running of their clinical trials and the appointment of a strong management team (to include a new CSO with 20+ years experience at GSK!).

 

Here’s the interview…Please accept preferences cookies to watch this video.

 

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member